A Randomized, Double-Blind, Placebo-Controlled Trial of Spironolactone on Carotid Intima-Media Thickness in Nondiabetic Hemodialysis Patients

Clinical Journal of the American Society of Nephrology - United States
doi 10.2215/cjn.09421209

Related search